Eisai and National Cancer Center Commence Joint Research and Development Project
Eisai and National Cancer Center Commence Joint Research and Development Project Using PDX With High Predictability of Clinical Outcomes, and Cancer Genome Data TOKYO, May 14, 2021 - (JCN Newswire) - Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning "Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare...
Eisai Co Ltd National Cancer Center Japan National Cancer Center Japan Agency For Medical Research Drug Discovery Accelerate Development
Source: finanznachrichten.de